Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes.
about
Aldosterone as a determinant of cardiovascular and renal dysfunctionImpairment in function and expression of transient receptor potential vanilloid type 4 in Dahl salt-sensitive rats: significance and mechanismQuantitative contribution of systemic vascular autoregulation in acute hypertension in conscious dogs.Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct.Mild DOCA-salt hypertension: sympathetic system and role of renal nervesAngiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice.Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.Serum angiotensin converting enzyme activity and the capacity to develop hypertention-associated arterial disease. Studies during the induction phase of one-kidney perinephritis hypertension in rabbits.α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.Effect of aldosterone and MR blockade on the brain and the kidney.Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction.Activation of the Renal PI3K/Akt/mTOR Signaling Pathway in a DOCA-Salt Model of Hypertension.Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension.Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertensionAngiotensin and NMDA receptors in the median preoptic nucleus mediate hemodynamic response patterns to stressSustained elevation of NF-κB activity sensitizes offspring of maternal inflammation to hypertension via impairing PGC-1α recovery.The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats.Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.Neuron-specific (pro)renin receptor knockout prevents the development of salt-sensitive hypertension.The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory StressAngiotensin II antagonists.Central infusion of aldosterone increases blood pressure by mechanisms independent of Na retention.Comparison of the vascular and glomerular changes in aortic-ligature and DOCA-salt hypertension.DOCA-salt hypertension impairs artery function in rat middle cerebral artery and parenchymal arteriolesMechanism of the response to captopril in glucocorticoid hypertension.Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats.Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease.Effects of lipopolysaccharide on vascular reactivity and mortality in rats.Hemodynamic changes induced by prolonged NaCl and DOCA administration in spontaneously hypertensive rats.Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats.Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.Anti-hypertension effects of traditional Chinese medicine ju-ling-tang on renal hypertensive rats.Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension.Central mechanisms in DOC-salt hypertensive rats.
P2860
Q28344356-34275654-A16E-47B5-8C24-12917C1B7D3DQ33822709-C636EE86-F673-472C-903B-9BB8E6BEB88EQ34581242-9A427E11-3840-4A0A-9001-C3A3389441AEQ34610189-C506A993-EBCB-4EC1-B7A9-7075AA75E08DQ34731561-4E3B0FD2-68CB-494B-8176-416BBF7A3B5FQ34979777-9F355A2C-7755-49EB-8DEE-D60D9FA6B951Q35130413-0877066E-F671-4487-8456-B3DA20FC6870Q35862920-7ACF38F1-E156-421D-A558-ADFDAB8EAAC5Q36058884-6239C1CE-38AA-441A-A888-D907768ED266Q36114331-C0D11E21-5B42-463B-BBAB-D6AA307E3CDAQ36158047-6D37954F-5A1D-4EAB-BC0B-F4E6EC5E0E19Q36229028-9D02A4F7-C97D-46DD-9473-5847042E7F16Q36514846-9E8E0B43-245C-46A1-AAD0-9147D8655614Q36612162-95BDD824-A6E6-49AD-A8AE-FA3A49137C42Q36955436-839AB4EC-8806-4C84-AA60-374CAC26F68DQ37127358-4D33F85F-40EE-4D23-A296-42EFE912C23CQ37247868-1CC820E2-6196-4EEA-A935-9F84541809E5Q37294696-9BEA2906-19BF-4E1A-8B81-820791A88EE3Q37510401-5551C313-0259-4EE8-8F3A-830212898557Q37626138-D1DC73B7-310A-4014-A607-167EACD2F10DQ37951441-BFE538F0-FBD3-4277-AAB6-474D0A44D781Q40794697-0AB6B5AB-261B-41C8-B77F-FADB9FFFE324Q41204359-F1C13A0B-689E-4262-84EC-93726145DD16Q41326961-243243DB-290A-425D-BF41-07BA97B9A78AQ41597227-482FEAEF-9171-421D-8EA8-D8185D8E54C2Q42245870-481D2E8F-B036-4D8C-93B5-0A00F1CF6E92Q43233470-6EC7D7F6-2F79-4C1B-801F-B145673B9687Q43670943-D51B72FD-5D1D-4A4D-B5D5-1ADE2BC3F9D7Q44515705-0D89C388-EF6B-4AD0-957E-A8F4C74A36E0Q45146065-31FDAE64-AE33-4CC8-AD47-01071B3A1CD9Q46179217-E2ED4E4A-CA4F-4BB0-8613-CB8319AF24EDQ46484270-19239326-8364-46D1-8A3C-DA1FF696A1BFQ46851788-DEAEDCE6-B2C5-430D-ABC5-4F24745A98C0Q50920264-3E1F9BC8-3BFB-4C47-AA0A-23EB4747C5D4Q54523368-7572D5AC-A7C2-4935-AC99-1CEDC7572A98
P2860
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Malignant hypertension resulti ...... nd sodium in vascular changes.
@en
type
label
Malignant hypertension resulti ...... nd sodium in vascular changes.
@en
prefLabel
Malignant hypertension resulti ...... nd sodium in vascular changes.
@en
P2093
P356
P1433
P1476
Malignant hypertension resulti ...... nd sodium in vascular changes.
@en
P2093
Brunner HR
Vaughan ED Jr
P304
P356
10.1161/01.RES.36.2.300
P577
1975-02-01T00:00:00Z